Advanced search
Publication Cover
Journal of Investigative Surgery Volume 16, 2003 - Issue 2
Submit an article Journal homepage
15
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Piroxicam-Induced Regression of Intestinal Adenomatous Polyps in APC Δ474 Mice

Z. F. Qiu Second Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
,
K. Maruyama Second Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
,
K. Sunayama Second Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
,
H. Kashiwabara Second Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
,
T. Shoji Second Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
,
T. Nakamura Second Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
,
S. Suzuki Second Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
,
H. Konno Second Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
&
S. Nakamura Second Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan
 show all
Pages 71-81 | Published online: 09 Jul 2009

  • Landis SH, Murray Y, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin. 1999;49:8-31.
  • Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechnie D, Finniear R, Markham A, Groffen J, Boguski MS, Altschul SF, Horii A, Ando H, Miyoshi Y, Miki Y, Nishisho I, Nakamura Y. Identification of FAP locus genes from chromozome 5q21.Science. 1991;253:661-665.
  • Kinzler KW, Vogelstein B. Cancer-susceptibility genes. Gate keepers and caretakers. Nature. 1997;386: 761-763.
  • Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science. 1990;19:247(4940);322-324.
  • Dubois RN, Giardello FM, Smalley WE. Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention. Gastroenterol Clin North Am. 1996;25:773791.
  • Chan TA, Morin PJ, Vogelstein B, Kinzler KW Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci USA. 1998;95:681-686.
  • Kimata H, Baba S. Clinical and experimental studies on chemoprevention of colorectal cancer using piroxicam. JJpn Soc Colo-Proctol. 1998;51:226-234.
  • Jacoby RF, Cole CE, Tursch K, Newton MA, Kelloff GJ, Hawk ET, Lubet RA. Chemopreventive efficacy of combined piroxicam and difluoromethylornitine treatment of Ape mutant Min mouse adenomas, and selective toxicity against Ape mutant embryos. Cancer Res. 2000;60:1864-1870.
  • Jacoby RF, Marshall DJ, Newton MA, Novakovic K, Tursch K, Cole CE, Lubet RA, Kelloff GJ, Verma A, Moser AR, Dove WF. Chemoprevention of spontaneous intestinal adenomas in the Ape Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res. 1996:56:710-714.
  • HIa T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA. 1992:89:7384-7388.
  • Earnest DL, Hixon LJ, Alberts DS. Piroxicam and other cyclooxygenase inhibitors' potential for Chemoprevention. J Cell Biochem. 1992;161(suppl):156-166.
  • Bennet A, Tacca MD, Stamford IF, Zebro T. Prostaglandins from tumuors of human large bowel. Br J Cancer. 1977:29:881-884.
  • Bennett A, Civier A, Hensby CN, Stamford IF. Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues. Gut. 1987:28:315-318.
  • Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, Dubois RN. Dp-regulation of cyclooxygenase 2 gene expression in human colorectal adenomasand adenocarcinomas. Gastroenterology. 1997:107:1183-1188.
  • Tsujii M, Dubois RN. Alterations in cellular adhesion and apoptosis in epithelial cells over-expressing prostaglandin endoperoxide synthase 2. Cell. 1995:83:493-501.
  • Paricha PJ, Bedi A, O'Connor K, Rashid A, Akhtar Aj, Zahurak ML, Piantadosi S, Hamilton SR, Giardiello FM. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology. 1995:109:994-998.
  • Ritland SR, Gendler SJ. Chemoprevention of intestinal adenomas in the ApcMin mouse by piroxicam: kinetics, strain effects and resistance to chemosuppression. Cardnogenesis. 1999;20:51-58.
  • Kondo Y, Arii S, Mori A, Furutani M, Chiba T, lmamura M. Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into L0V0 human colon cancer cell line. CIin Cancer Res. 2000:6:622-630.
  • Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, MeIi S, Gasparini G. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer lnst. 1992:84:1875-1887.
  • Grunstein J, Roberts WG, Mathieu-Costello O, Hanahan D, Johnson RS. Tumor-derived expression of vascular endothelial cell growth factor is a critical factor in tumor expansion and vascular function. Cancer Res. 1999:59:1592-1598.
  • Sasai H, Masaki M, Wakitani K. Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta474) by a novel COX-2 inhibitor, JTE-522. Carcinogenesis. 2000;21(5):953-958.
  • Hull MA, Booth JK, Tisbury A, Scott N, Bonifer C, Markham AM, Coletta PL. Cyclooxygenase 2 is upregulated and localized to macrophages in the intestine of Min mice. Br J Cancer. 1999:79:13991405.
  • Fosslien E. Molecular pathology of cyclooxygenase-2 in neoplasia. Ann Clin Lab Sci. 2000:30:3-21.
  • Sonoshita M, Takaku K, Sasaki N, Sugimoto Y, Ushikubo F, Narumiya S, Oshima M, Taketo MM. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc (Delta 716) knockout mice. Nat Med. 2001:7:10481051.
  • Grosch S, Tegeder I, Niederberger E, Brautigam L, Geisslinger G. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. FASEBJ. 2001 ;15:2742-2744.
  • Morishita Y, Yoshimi N, Kawabata K, Sugie S, Tanaka T, Mori H. Regressive effects of various chemopreventive agents on azoxymethane-induced aberrant crypt foci in the rat colon. Jpn J Cancer Res. 1997;88:815-820.
  • Jacoby RF, Marshall DJ, Newton MA, Novakovic K, Tutsch K, Cole CE, Lubet RA, Kelloff GJ, Verma A, Moser AR, Dove WF. Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal antiinflammatory drug piroxicam. Cancer Res. 1996:56:710-714.
  • Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, Dubois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998;93:705-716.
  • Jacoby RF, Seibert K, Cole CE, Kelloff G, Lubert RA. The cyclooxygenase-2 inhibitor is a potent and therapeutic agent in the mouse model of adenomatous polyposis. Cancer Res. 2000;60:5040-5044.
  • LaI G, Ash C, Hay K, Redston M, Kwong E, Hancock B, Mak T, Kargman S, Evans JF, Gallinger S. Suppression of intestinal polyps in Msh2-deficient and non-Msh2deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase1/2 inhibitor. Cancer Res. 2001;61:6131-6136.
  • Celis JE, Celis A. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells. Proc Natl Acad Sci USA. 1985:82:3262-3266.
  • Kubben FJ, Peeters-Hoesevoets A, Engels LG, Baeten CG, Schutte B, Arenas JW, Stockbrugger RW, Blijham GH. Proliferating cell nuclear antigen (PCNA): A new marker to study human colonie cell proliferation. Gui. 1994;35:530535.
  • Frenkian M, Segond N, Pidoux E, Cohen R, Jullienne A. lndomethacin, a cox inhibitor, enhances 15-PGDH and decreases human tumoral C cells proliferation. Prostaglandins Other Lipid Mediat 2001 ;65:11-20.
  • Li H, Kramer PM, Lubet RA, Steele VE, Kelloff GJ, Pereira MA. Termination of piroxicam treatment and the occurrence of azoxymethane-induced colon cancer in rats. Cancer Lett. 1999;147:187-193.
  • Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, Dubois RN. Dp-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994:107:1183-1188.
  • Dempke W, Rie C, Grothey A, Schmoll HJ. Cyclooxygenase-2: A novel target for cancer chemotherapy? J Cancer Res Clin Oncol. 2001 ; 127:411-417.
  • Goss KH, Groden J. Biology of the adenomatous polyposis coli tumor suppressor. J Clin Oncol. 2000;18:1967-1979.
  • Szabo IL, Pal R, Soreghan B, Jones MK, Baatar D, Kawanaka H, Tarnawski AS. NSAIDs inhibit the activation of egr-1 gene in mivrovascular endothelial cells. A key to inhibition of angiogenesis? J Physiol Paris. 2001 ;95:379-383.
  • Pereira MA, Barnes LH, Steele VE, Kelloff GV, Lubet RA. Piroxicam-induced regression of azoxymethane-induced aberrant crypt foci and prevention of colon cancer in rats. Carclnogenesis. 17:373-376.
  • Hixson U, Earnest DL, Fennerty MB, Sampliner RE. NSAID effect on sporadic colon polyps. Am J Gastroenterol. 1993:88:1652-1656.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.